Glaxosmithkline Pharmaceutical logo

Glaxosmithkline Pharmaceutical share price

NSE: GLAXO · Healthcare

₹2,651.70 -0.78%

Closing price data, updated 17 Nov 2026. 52-week range: -15.0% from high, +27.0% above low.

Price₹2,651.70
Market cap₹44,921 Cr
P/E39.2
P/B23.88
ROE49.1%
ROCE55.4%
Debt / equity0.01
Dividend yield0.00%
EPS₹67.68
Book value₹111.04
Operating margin32.8%
Dipscan score59 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Glaxosmithkline Pharmaceutical shareholding pattern

As of Sep 2026: Promoters 75.00%, FIIs 4.75%, DIIs 8.48%, Government 0.00%, Public 9.65%, Others 2.12%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters75.00%75.00%75.00%75.00%75.00%75.00%
FIIs4.75%4.79%4.62%4.64%4.80%4.89%
DIIs8.48%7.80%7.68%7.70%7.75%7.70%
Government0.00%0.00%0.00%0.00%0.00%0.00%
Public9.65%10.21%10.35%10.36%10.34%10.32%
Others2.12%2.20%2.35%2.30%2.11%2.09%
No. of Shareholders119,337126,087121,763122,460122,904123,629

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
-0.78%+5.03%+4.44%-0.60%+9.72%+7.08%

Growth

Sales growth, 3 years+5.7%
Sales growth, 5 years–
Profit growth, 3 years+19.3%
Profit growth, 5 years–
Latest quarter sales vs last year–
Latest quarter profit vs last year–

Strengths and weaknesses

Strengths

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Glaxosmithkline Pharmaceutical?

Glaxosmithkline Pharmaceutical (GLAXO) last closed at ₹2,651.70 (-0.78% on the day).

What is the market cap of Glaxosmithkline Pharmaceutical?

About ₹44,921 Cr.

What is the P/E ratio of Glaxosmithkline Pharmaceutical?

The price-to-earnings ratio is 39.2, and return on equity is 49.1%.

Figures are calculated from company results and exchange prices and are for information only.